PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.\', \'Center for Ophthalmology, University Eye Hospital Tübingen, Tübingen, Germany.\', \'Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany.\', \'Department of Ophthalmology, University of Bonn, Bonn, Germany.\', \'Herzog Carl Theodor Eye Hospital, Munich, Germany.\', \'Novartis Pharma GmbH, Roonstrasse 25, 90429, Nürnberg, Germany.\', \'Novartis Pharma AG, Basel, Switzerland.\', \'Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Novartis Pharma GmbH, Roonstrasse 25, 90429, Nürnberg, Germany. benjamin.gmeiner@novartis.com.\', \'Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. benjamin.gmeiner@novartis.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-06362-w
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35181697
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • A model to quantify the influence of treatment patterns and optimize outcomes in nAMD.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35181697>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35181697>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all